Press Releases about Arrowhead Pharma
Arrowhead Pharmaceuticals Reports Fiscal 2021 Year End Results
November 22, 2021
Via Business Wire
Arrowhead Announces JNJ-75220795 in Development for NASH
November 17, 2021
Via Business Wire
Arrowhead Presents New Clinical Data on ARO-APOC3 at AHA 2021
November 15, 2021
Via Business Wire
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Year End Results
November 01, 2021
Via Business Wire
Via Business Wire
Arrowhead Earns $10 Million Phase 1 Milestone Payment
September 28, 2021
Via Business Wire
Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
July 02, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|